Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2018

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

(1) , , , , (1) , , , , , (1) , (1) , (1) , (1) , (1) , , (1)
1

Dates and versions

hal-02143630 , version 1 (29-05-2019)

Identifiers

Cite

Norbert Vey, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, et al.. Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients. Blood, 2018, 132 (1), ⟨10.1182/blood-2018-99-119263⟩. ⟨hal-02143630⟩

Collections

CNRS UNIV-AMU CRCM
27 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More